BACKGROUND: Hypercholesterolemia (HC) and atherosclerosis can elicit oxidative stress, coronary endothelial dysfunction, and myocardial ischemia, which may induce growth-factor expression and lead to myocardial neovascularization. We tested the hypothesis that chronic antioxidant intervention in HC would attenuate neovascularization and preserve the expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF). METHODS AND RESULTS: Three groups of pigs (n=6 each) were studied after 12 weeks of normal or 2% HC diet or HC+antioxidant supplementation (100 IU/kg vitamin E and 1 g vitamin C daily). Myocardial samples were scanned ex vivo with a novel 3D micro-CT scanner, and the spatial density and tortuosity of myocardial microvessels were determined in situ. VEGF mRNA, protein levels of VEGF and VEGF receptor-1, HIF-1alpha, nitrotyrosine, and superoxide dismutase (SOD) were determined in myocardial tissue. The HC and HC+antioxidant groups had similar increases in serum cholesterol levels. HC animals showed an increase in subendocardial spatial density of microvessels compared with normal (160.5+/-11.8 versus 95.3+/-8.2 vessels/cm2, P<0.05), which was normalized in HC+antioxidant (92.5+/-20.5 vessels/cm2, P<0.05 versus HC), as was arteriolar tortuosity. In addition, HC induced upregulation of VEGF, HIF-1alpha, and nitrotyrosine expression and decreased SOD expression and activity, all of which were preserved by antioxidant intervention. CONCLUSIONS: Changes in myocardial microvascular architecture invoked by HC are accompanied by increases in HIF-1alpha and VEGF expression and attenuated by antioxidant intervention. This underscores a role of increased oxidative stress in modulating myocardial microvascular architecture in early atherogenesis.
BACKGROUND:Hypercholesterolemia (HC) and atherosclerosis can elicit oxidative stress, coronary endothelial dysfunction, and myocardial ischemia, which may induce growth-factor expression and lead to myocardial neovascularization. We tested the hypothesis that chronic antioxidant intervention in HC would attenuate neovascularization and preserve the expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF). METHODS AND RESULTS: Three groups of pigs (n=6 each) were studied after 12 weeks of normal or 2% HC diet or HC+antioxidant supplementation (100 IU/kg vitamin E and 1 g vitamin C daily). Myocardial samples were scanned ex vivo with a novel 3D micro-CT scanner, and the spatial density and tortuosity of myocardial microvessels were determined in situ. VEGF mRNA, protein levels of VEGF and VEGF receptor-1, HIF-1alpha, nitrotyrosine, and superoxide dismutase (SOD) were determined in myocardial tissue. The HC and HC+antioxidant groups had similar increases in serum cholesterol levels. HC animals showed an increase in subendocardial spatial density of microvessels compared with normal (160.5+/-11.8 versus 95.3+/-8.2 vessels/cm2, P<0.05), which was normalized in HC+antioxidant (92.5+/-20.5 vessels/cm2, P<0.05 versus HC), as was arteriolar tortuosity. In addition, HC induced upregulation of VEGF, HIF-1alpha, and nitrotyrosine expression and decreased SOD expression and activity, all of which were preserved by antioxidant intervention. CONCLUSIONS: Changes in myocardial microvascular architecture invoked by HC are accompanied by increases in HIF-1alpha and VEGF expression and attenuated by antioxidant intervention. This underscores a role of increased oxidative stress in modulating myocardial microvascular architecture in early atherogenesis.
Authors: J J Whyte; M Samuel; E Mahan; J Padilla; G H Simmons; A A Arce-Esquivel; S B Bender; K M Whitworth; Y H Hao; C N Murphy; E M Walters; R S Prather; M H Laughlin Journal: Transgenic Res Date: 2010-12-18 Impact factor: 2.788
Authors: Alejandro R Chade; Xiang-Yang Zhu; James D Krier; Kyra L Jordan; Stephen C Textor; Joseph P Grande; Amir Lerman; Lilach O Lerman Journal: Stem Cells Date: 2010-06 Impact factor: 6.277
Authors: Martin Rodriguez-Porcel; Xiang-Yang Zhu; Alejandro R Chade; Beatriz Amores-Arriaga; Noel M Caplice; Erik L Ritman; Amir Lerman; Lilach O Lerman Journal: Am J Physiol Heart Circ Physiol Date: 2005-10-07 Impact factor: 4.733
Authors: Xin Zhang; Victor H Urbieta-Caceres; Alfonso Eirin; Caitlin C Bell; John A Crane; Hui Tang; Kyra L Jordan; Yun-Kyu Oh; Xiang-Yang Zhu; Michael J Korsmo; Adi R Bachar; Pinchas Cohen; Amir Lerman; Lilach O Lerman Journal: Life Sci Date: 2012-07-20 Impact factor: 5.037
Authors: Xiang-Yang Zhu; Victor Urbieta-Caceres; James D Krier; Stephen C Textor; Amir Lerman; Lilach O Lerman Journal: Stem Cells Date: 2013-01 Impact factor: 6.277
Authors: Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman Journal: J Hypertens Date: 2014-01 Impact factor: 4.844
Authors: Mark D Stevenson; Chandrika Canugovi; Aleksandr E Vendrov; Takayuki Hayami; Dawn E Bowles; Karl-Heinz Krause; Nageswara R Madamanchi; Marschall S Runge Journal: Antioxid Redox Signal Date: 2018-12-28 Impact factor: 8.401
Authors: Jing Lin; Xiangyang Zhu; Alejandro R Chade; Kyra L Jordan; Ronit Lavi; Elena Daghini; Matthew E Gibson; Angelo Guglielmotti; Amir Lerman; Lilach O Lerman Journal: Arterioscler Thromb Vasc Biol Date: 2009-07-23 Impact factor: 8.311